Viatris Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. Welcome to Day 2 of the Barclays Healthcare Conference. Continuing the [spectrum] track for the day, I'm delighted to have the management of Viatris with me. Just like what the slide says, we have Mike Goettler, the CEO of Viatris with us; and Rajiv Malik, President; and Sanjeev Narula, the CFO.
Questions & Answers
So starting with -- this is going to be a fireside comment -- fireside chat format. And really since the last 15 days, Mike and Rajiv, Sanjeev, in further discussions, right, think -- I don't think you would have expected the reaction to your announcement, the way the stock has reacted. Investors are understandably in angst. So let's speak about capital allocation. Basically, what do you think about the biosimilars business and exiting the business and then investing in the newer assets, which is asset undisclosed or newer areas? And how do you think competitors, in terms of, like, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |